UBS raises MiniMed Group price target to $28 from $25
UBS maintained a Buy rating on MiniMed Group and raised its price target to $28.00 per share from $25.00, according to Benzinga via TradingView News.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.